ResMed SEC filings, summarized
We read every ResMed 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track RMD in your inbox
Add ResMed to your watchlist — free, every morning.
Recent filings
ResMed CEO Michael Farrell sells $1.13M in stock
Michael J. Farrell, ResMed’s chairman and CEO and a director, sold 4,991 shares of common stock on Oct. 7 at $226.33 per share, for approximately $1.13…
ResMed CEO Michael Farrell sells $1.1M in stock
Michael J. Farrell, ResMed’s chairman and CEO and a director, sold 4,991 shares of common stock on Sept. 8 at $222.44 per share, for approximately $1.11…
ResMed starts $450 million accelerated share repurchase with Citibank
ResMed entered into an accelerated share repurchase agreement with Citibank on August 31, 2026, and will pay $450 million on September 3, funded by proceeds…
ResMed appoints Carol Burt as lead director as Ron Taylor plans retirement
ResMed announced that Carol Burt, a board member since 2013 and current Nominating and Governance Committee chair, will become lead director on November 15,…
ResMed Names Carol Burt Lead Director as Ron Taylor Plans Board Retirement
ResMed said Carol Burt will become lead director on November 15, 2026, succeeding Ron Taylor, who will retire from the board after more than 21 years of…
ResMed replaces KPMG with PwC as independent auditor
ResMed dismissed KPMG on August 13, 2026, and appointed PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year…
ResMed CEO Michael Farrell sells $1.03M in stock
ResMed Chairman and CEO and Director Michael J. Farrell sold 4,991 shares of common stock on Aug. 7 at $205.69 per share, for approximately $1.03 million.…
ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of…
ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of operations (Exhibit 99.1). Signed by CFO Brett Sandercock.…
ResMed ($RMD) board declared a quarterly cash dividend of $0.60/share.
ResMed ($RMD) board declared a quarterly cash dividend of $0.60/share. Record date Feb 12, 2026; ex-dividend date Feb 11, 2026; payable Mar 19, 2026.…
ResMed ($RMD) furnished a press release (Exhibit 99.1) on Jan 29, 2026 reporting results for the quarter…
ResMed ($RMD) furnished a press release (Exhibit 99.1) on Jan 29, 2026 reporting results for the quarter ended Dec 31, 2025. Investors: see the release for…